Ann: European approvals and milestone payments for Lenzetto, page-5

  1. 494 Posts.
    Agree, its a fully funded biotech - you are buying an option of growth (assuming they can develop / adapt something) with very low risk of equity dilution.

    Worst case you get 60c value of the axiron royalties, and anything more is all upside
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.8¢
Change
-0.002(10.0%)
Mkt cap ! $7.366M
Open High Low Value Volume
1.8¢ 1.8¢ 1.8¢ $8.471K 470.6K

Buyers (Bids)

No. Vol. Price($)
1 50000 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 370600 1
View Market Depth
Last trade - 13.32pm 25/07/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.